載入...
Mechanisms of immune evasion and current status of checkpoint inhibitors in non‐small cell lung cancer
In the past several years, immunotherapy has emerged as a viable treatment option for patients with advanced non‐small cell lung cancer (NSCLC) without actionable driver mutations that have progressed on standard chemotherapy. We are also beginning to understand the methods of immune evasion employe...
Na minha lista:
| 發表在: | Cancer Med |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5055165/ https://ncbi.nlm.nih.gov/pubmed/27416962 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.819 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|